User:Jack Guckien/Sandbox1
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
[http://ncbi.nlm.gov/pmc/articles/PMC5707151 Discovery, characterization, and clinical development of glucagon-like peptides] | [http://ncbi.nlm.gov/pmc/articles/PMC5707151 Discovery, characterization, and clinical development of glucagon-like peptides] | ||
=== Relevance === | === Relevance === | ||
| - | + | ||
== Structure == | == Structure == | ||
<scene name='10/1037513/Example1/1'>Example1Scene</scene> | <scene name='10/1037513/Example1/1'>Example1Scene</scene> | ||
| Line 14: | Line 14: | ||
===Active Site=== | ===Active Site=== | ||
| - | + | <scene name='10/1037513/7rgp_-_tirzepatide_bound/2'>Tirzepatide Bound Overview</scene> | |
==Drug Applications== | ==Drug Applications== | ||
Revision as of 19:03, 26 March 2024
| |||||||||||
